Key Points

• PATH opened at $16.24, down from a prior close of $18.22, and fell further to around $15.66 after earnings
• Q2 revenue came in at $410.3 million, up 13.3% year over year, beating the $397.8 million estimate
• Billings missed slightly at $375.5 million, and growth was seen as too slow compared to AI software peers
• UiPath raised its fiscal 2027 revenue forecast to $1.789-$1.794 billion
• Analyst consensus remains "Hold" with a price target of $15.73; CEO Daniel Dines sold over $22 million in stock last month

UiPath (PATH) dropped more than 16% on September 4 after reporting Q2 fiscal 2027 earnings that beat on revenue but failed to impress a market with high expectations for AI-linked companies.

The company, one of the leading vendors in robotic process automation (RPA) — software that automates repetitive business tasks such as data entry and invoice processing — went public on the New York Stock Exchange in 2021 and has since traded far below its debut-era highs, a backdrop that shapes how investors respond to each earnings report.

The stock opened at $16.24, sharply below the prior close of $18.22, and last traded near $15.12. That puts PATH at 21.6% below its 52-week high of $19.29, reached in December 2025.

Quarterly revenue came in at $410.3 million, up 13.3% year over year and ahead of the Wall Street estimate of $397.8 million. Non-GAAP earnings per share of $0.15 matched expectations. Billings, however, came in at $375.5 million, a slight miss. Management pointed to longer customer decision-making cycles as enterprises weigh traditional versus AI-driven automation.

CEO Daniel Dines noted that 18 of UiPath's top 20 deals this quarter included AI, framing the business as a beneficiary of enterprise AI adoption rather than a victim of it. The stakes of that framing are real for the sector: as large language models and AI agents take on more workflow automation tasks, established RPA vendors face pressure to show their platforms can absorb AI capabilities rather than be displaced by them. Still, the market was not convinced.

Growth Pace Falls Short of AI-Era Expectations

Annual recurring revenue grew 12% to $1.938 billion, and UiPath posted its fourth consecutive quarter of GAAP profitability. The company also raised its full-year revenue outlook to $1.789-$1.794 billion and guided for roughly $445 million in non-GAAP operating income.

Q3 guidance of $440 million to $445 million came in slightly above consensus, but investors had priced in something bigger following the stock's roughly 9% gain just eight days earlier.

The core concern is straightforward: 12-13% growth looks modest next to faster-moving AI software names, and questions remain about whether AI will eventually undercut demand for traditional automation tools.

New CFO Hitesh Ramani acknowledged this, saying UiPath is taking a "prudent approach" to guidance given macroeconomic variability and shifting customer adoption patterns.

Analyst Ratings Hold Steady

Analyst reaction was measured. BMO Capital Markets raised its price target from $13 to $18 but kept a Market Perform rating. Wells Fargo moved its target from $13 to $15 with an Equal Weight rating. Royal Bank of Canada went from $15 to $17 at Sector Perform. DA Davidson raised its target from $12 to $16 at Neutral, and TD Cowen moved from $13 to $16 at Hold.

Of 19 analysts covering the stock, 16 rate it Hold, two rate it Buy, and one rates it Sell. The consensus price target sits at $15.73.

Adding to the cautious tone, CEO Daniel Dines sold 1.4 million shares on August 19 at an average price of $16.07, a transaction worth over $22.5 million. He still holds more than 26 million shares.

Institutional holders including State Street, Morgan Stanley, and AQR Capital have all increased their positions in recent quarters. Institutional investors now own 62.5% of the stock.

PATH is down 4.8% year to date, and investors who bought $1,000 worth of the stock five years ago would have roughly $242 today.

Source: CoinCentral